BIOBANKS: ANTARES VISION GROUP PRESENTS THE NEW AVBP PLATFORM

THE INTEGRATED ECOSYSTEM TO MANAGE THE LIFE CYCLE OF BIOLOGICAL SAMPLES

Antares Vision S.p.A., a leading multinational company in traceability and quality control, which guarantees product safety and supply chain transparency through integrated data management, announces the launch of Antares Vision Biobanking Platform (AVBP), the next-generation technology platform designed to digitize, standardize and automate all the core operations of modern biobanks.

 ​

Biobanks today represent a strategic infrastructure for the progress of biomedical research, oncology, translational medicine, and epidemiological studies. ​The global market is estimated to be between about $55 and $87 billion in 2022-2025, highlighting a development trend that reflects the strategic importance of these resources. ​In this context, Italy has about 90 biobanks or biological resource centers connected to the national and international network through the Italian node of BBMRI-ERIC (Biobanking and Biomolecular Resources Research Infrastructure).

 ​

However, the increasing complexity in the management of biological samples requires digital solutions that can ensure accuracy, control, and business continuity. ​Antares Vision Biobanking Platform, already available for implementation in research facilities, hospitals and biomedical networks, was created to meet these new challenges, offering a highly integrated ecosystem that supports the entire life cycle of samples. ​With AVBP, Antares Vision consolidates its commitment to supporting scientific research and precision medicine, offering advanced digital tools for the safe, efficient, and compliant management of biological samples. ​The AVBP platform introduces advanced features including:

  • End-to-end traceability of the sample life cycle;
  • Real-time localization with flexible and intuitive mapping of freezers, racks, boxes and locations, even in complex or multi-site facilities;
  • Data management compliant with international standards (ISBER, MIABIS), with a complete audit trail, digitized SOPs and tools to ensure data quality, integrity and reproducibility;
  • Automation of operational workflows, significant reduction of manual errors and optimization of management times, from taking charge to picking;
  • Native integration with external systems (LIMS, EHR/EMR, research registers and other scientific platforms) via standard APIs and interoperability protocols;
  • Scalability and security thanks to modular, cloud-ready architecture equipped with advanced protocols for the protection.

 ​

Accessible via the web – even from mobile devices – AVBP accompanies and optimizes all operational phases: acceptance, cataloging, storage, consultation, collection, handling and shipping. ​The result is a solution designed to ensure maximum efficiency, business continuity, regulatory compliance and a higher level of quality in sample management.

 ​“With AVBP, we transform biobanks into truly smart infrastructures, fully tracked, monitored, and integrated with the digital research ecosystem. ​The platform allows not only rigorous control of the sample, but also smoother process management, greater data reliability and a concrete contribution to personalized medicine,” says Adriano Fusco, Director of the Digital Healthcare Department of Antares Vision Group